BosMed 500 Canada
Natural health product licensed in Canada
- Other names
- BosMed 500, BosMed 500 Advanced Boswellia, BosMed 500 Canada Advanced Boswellia, Euromedica BosMed 500, Euromedica BosMed 500 Advanced Boswellia, Euromedica BosMed 500 Canada, Euromedica BosMed 500 Canada Advanced Boswellia, Terry Naturally BosMed 500, Terry Naturally BosMed 500 Advanced Boswellia, Terry Naturally BosMed 500 Canada, Terry Naturally BosMed 500 Canada Advanced Boswellia
- Licence holder
- Europharma Inc.
- NPN or DIN-HM
- 80073953
- Status
- Active licence
- Licence date
- 22 November 2016
- Revision date
- 18 January 2017
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Boswellia serrata Source : Gum oleoresin Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 5,000 milligramme Potency : 40 % Boswellic acids | 500 milligramme | Not calculated |
| Boswellia serrata Source : Gum oleoresin Potency : 0 >10% 3-Acetyl-11-keto-beta-boswellic acid | Not specified | Not calculated |
Non-medicinal ingredients
Glycérine, Gélatine, Cire d'abeille jaune, Eau purifiée, Huile de tournesol, Dioxyde de titane, Annatto extract
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine as an anti-inflammatory to help relieve joint pain and swelling.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80073953
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging